Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

Europe - FRA:AMC - US0126531013 - Common Stock

75.05 EUR
+0.85 (+1.15%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMC. AMC was compared to 69 industry peers in the Chemicals industry. The financial health of AMC is average, but there are quite some concerns on its profitability. While showing a medium growth rate, AMC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AMC had negative earnings in the past year.
AMC had a positive operating cash flow in the past year.
AMC had positive earnings in 4 of the past 5 years.
In the past 5 years AMC always reported a positive cash flow from operatings.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

AMC has a Return On Assets of -6.34%. This is in the lower half of the industry: AMC underperforms 79.71% of its industry peers.
AMC's Return On Equity of -10.70% is on the low side compared to the rest of the industry. AMC is outperformed by 73.91% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

AMC's Gross Margin of 7.76% is on the low side compared to the rest of the industry. AMC is outperformed by 86.96% of its industry peers.
In the last couple of years the Gross Margin of AMC has declined.
AMC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMC has about the same amout of shares outstanding than it did 1 year ago.
AMC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMC has an improved debt to assets ratio.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AMC has an Altman-Z score of 1.73. This is a bad value and indicates that AMC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMC (1.73) is worse than 68.12% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that AMC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.31, AMC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACC8.14%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 2.31. This indicates that AMC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.31, AMC is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
A Quick Ratio of 1.47 indicates that AMC should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.47, AMC is doing good in the industry, outperforming 72.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The earnings per share for AMC have decreased strongly by -155.42% in the last year.
Looking at the last year, AMC shows a very negative growth in Revenue. The Revenue has decreased by -33.05% in the last year.
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

The Earnings Per Share is expected to grow by 63.36% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.24% on average over the next years. This is quite good.
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue Next Year-9.81%
Revenue Next 2Y-1.33%
Revenue Next 3Y4.37%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMC. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 413.19, AMC can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AMC is valued a bit more expensive than the industry average as 72.46% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, AMC is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 413.19
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

75.36% of the companies in the same industry are cheaper than AMC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.31
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AMC's earnings are expected to grow with 56.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.61%
EPS Next 3Y56.79%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.91%, AMC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.11, AMC has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, AMC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

The dividend of AMC is nicely growing with an annual growth rate of 13.04%!
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AMC are negative and hence is the payout ratio. AMC will probably not be able to sustain this dividend level.
The dividend of AMC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-32.53%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

FRA:AMC (9/26/2025, 7:00:00 PM)

75.05

+0.85 (+1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners99.06%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap8.83B
Analysts68.13
Price Target70.97 (-5.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend2.27
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)0.11%
PT rev (3m)1.82%
EPS NQ rev (1m)-7.59%
EPS NQ rev (3m)-137.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.24%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 413.19
P/S 2.08
P/FCF N/A
P/OCF 13.3
P/B 1.01
P/tB 1.24
EV/EBITDA 28.31
EPS(TTM)-2.31
EYN/A
EPS(NY)0.18
Fwd EY0.24%
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)5.64
OCFY7.52%
SpS36.15
BVpS74.13
TBVpS60.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.73
F-Score4
WACC8.14%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.81%
Revenue Next 2Y-1.33%
Revenue Next 3Y4.37%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%